Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Leukemia|October 12, 1999
Identification of novel chromosomal rearrangements in acute myelogenous leukemia involving loci on chromosome 2p23, 15q22 and 17q21A Melnick, S Fruchtman, A Zelent, et al.
Frontiers in Cell and Developmental Biology|April 10, 2023
Dual inhibition of EZH2 and G9A/GLP histone methyltransferases by HKMTI-1-005 promotes differentiation of acute myeloid leukemia cellsY Sbirkov, T Schenk, C Kwok, et al.
The Journal of Experimental Zoology|August 1, 1992
Genetic linkage analysis of the murine developmental mutant velvet coat (Ve) and the distal chromosome 15 developmental genes Hox-3.1, Rar-g, Wnt-1, and Krt-2C P Hart, J G Compton, S H Langley, et al.
Genomics|August 1, 1991
Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomesM G Mattei, M Rivière, A Krust, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptorsZ Chen, F Guidez, P Rousselot, et al.
Leukemia|January 1, 1993
Localization of the chromosome 15 breakpoints and expression of multiple PML-RAR alpha transcripts in acute promyelocytic leukemia: a study of 28 Chinese patientsJ P Geng, J H Tong, S Dong, et al.
The Journal of Clinical Investigation|May 1, 1993
Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemiaS J Chen, A Zelent, J H Tong, et al.
Oncogene|May 28, 2008
Retinoblastoma protein and the leukemia-associated PLZF transcription factor interact to repress target gene promotersK Petrie, F Guidez, J Zhu, et al.
Blood|October 6, 2001
Lineage restriction of the RARalpha gene expression in myeloid differentiationJ Zhu, C M Heyworth, A Glasow, et al.
Oncogene|February 19, 1999
Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patientM H Koken, M T Daniel, M Gianni, et al.
Pageof 6